US 10053689
Methods for increasing efficacy of lipid formulated siRNA
granted A61KA61K31/366A61K31/567
Quick answer
US patent 10053689 (Methods for increasing efficacy of lipid formulated siRNA) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/366, A61K31/567, A61K31/7088, A61K9/127